T-group (topology)
321.2.1 C-terminal domain in urocanase
Ligands and drugs
200
Member domains
20
with ligand contacts (≤ 4 Å)
10.0% of members
16
with DrugDomain annotations
8.0% of members
16
with a DrugBank compound
8.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 321.2.1 belongs to X-group 321 Glutamine synthetase-like, which binds 6.7 ligand superclasses per 20 proteins, narrower than 65% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB14128 | NAD | Nadide | 16 |
| DB01971 | URO | trans-urocanic acid | 5 |
| DB00139 | SIN | Succinic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 20 |
| URO | (2E)-3-(1H-IMIDAZOL-4-YL)ACRYLIC ACID | 5 |
| O66 | 3-[(4~{R})-5-oxidanylidene-1,4-dihydroimidazol-4-yl]propanoic acid | 1 |
| SIN | SUCCINIC ACID | 1 |